Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension
- PMID:24433082
- DOI:10.1165/rcmb.2013-0349OC
Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension
Abstract
Occlusive vasculopathy with intimal hyperplasia and plexogenic arteriopathy are severe histopathological changes characteristic of pulmonary arterial hypertension (PAH). Although a phenotypic switch in pulmonary endothelial cells (ECs) has been suggested to play a critical role in the formation of occlusive lesions, the pathobiology of this process is poorly understood. The goal of this study was to identify novel molecular mechanisms associated with EC dysfunction and PAH-associated bone morphogenetic protein receptor 2 (BMPR2) deficiency during PAH pathogenesis. A bioinfomatics approach, patient samples, and in vitro experiments were used. By combining a metaanalysis of human idiopathic PAH (iPAH)-associated gene-expression microarrays and a unique gene expression-profiling technique in rat endothelium, our bioinformatics approach revealed a PAH-associated dysregulation of genes involving chromatin organization, DNA metabolism, and repair. Our hypothesis that altered DNA repair and loss of genomic stability play a role in PAH was supported by in vitro assays where pulmonary ECs from patients with iPAH and BMPR2-deficient ECs were highly susceptible to DNA damage. Furthermore, we showed that BMPR2 expression is tightly linked to DNA damage control because excessive DNA damage leads to rapid down-regulation of BMPR2 expression. Moreover, we identified breast cancer 1 (BRCA1) as a novel target for BMPR2 signaling and a novel modulator of pulmonary EC homeostasis. We show here that BMPR2 signaling plays a critical role in the regulation of genomic integrity in pulmonary ECs via genes such as BRCA1. We propose that iPAH-associated EC dysfunction and genomic instability are mediated through BMPR2 deficiency-associated loss of DNA damage control.
Similar articles
-
Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.J Heart Lung Transplant. 2015 Mar;34(3):468-78. doi: 10.1016/j.healun.2014.09.011. Epub 2014 Sep 28. J Heart Lung Transplant. 2015. PMID:25447587
-
CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.J Mol Cell Cardiol. 2018 Mar;116:41-56. doi: 10.1016/j.yjmcc.2018.01.016. Epub 2018 Jan 31. J Mol Cell Cardiol. 2018. PMID:29374556
-
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.Circ Res. 2006 Feb 3;98(2):209-17. doi: 10.1161/01.RES.0000200180.01710.e6. Epub 2005 Dec 15. Circ Res. 2006. PMID:16357305
-
Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials.Pharmacol Ther. 2010 Apr;126(1):1-8. doi: 10.1016/j.pharmthera.2009.12.006. Epub 2010 Feb 1. Pharmacol Ther. 2010. PMID:20117135 Review.
-
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.Cell Mol Life Sci. 2017 Aug;74(16):2979-2995. doi: 10.1007/s00018-017-2510-4. Epub 2017 Apr 26. Cell Mol Life Sci. 2017. PMID:28447104 Free PMC article. Review.
Cited by37articles
-
Pulmonary Arterial Hypertension: A Deeper Evaluation of Genetic Risk in the -Omics Era.Genes (Basel). 2021 Nov 16;12(11):1798. doi: 10.3390/genes12111798. Genes (Basel). 2021. PMID:34828405 Free PMC article.
-
Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.2021年循环。Jul 6;144(1):52-73. doi: 10.1161/CIRCULATIONAHA.120.047978. Epub 2021 Jun 3. 2021年循环。。 PMID:34078089
-
The Third Man: DNA sensing as espionage in pulmonary vascular health and disease.Pulm Circ. 2021 Mar 2;11(1):2045894021996574. doi: 10.1177/2045894021996574. eCollection 2021 Jan-Mar. Pulm Circ. 2021. PMID:33738095 Free PMC article. Review.
-
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?Biomedicines. 2021 Jan 9;9(1):57. doi: 10.3390/biomedicines9010057. Biomedicines. 2021. PMID:33435311 Free PMC article. Review.
-
Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.Cardiovasc Res. 2021 Sep 28;117(11):2309-2325. doi: 10.1093/cvr/cvaa350. Cardiovasc Res. 2021. PMID:33399862 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous